Variant Bio, a private biotech firm, said on Tuesday it has launched a platform that uses artificial intelligence on genetic ...

Variant Bio, a genomics-driven AI drug discovery company, today announced the launch of Inference, the world's first agentic genomic drug dis ...

A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...

A rare flu variant that has shown some resistance to the most commonly used antiviral treatment has been detected in at least two people in the United States, according to the US Centers for Disease ...

Officials at Variant Bio report that the company is transitioning from a firm focused on identifying genomic variants that uncover the basis of disease resistance to one that now also transforms those ...

As flu cases rise across the U.S., those who end up contracting the virus have treatments available that may help reduce ...

As bird flu continues to make headlines, the more common variant of influenza hasn’t garnered as much attention as of late. However, according to a new study from the Centers for Disease Control and ...

After hinting COVID-19 drug Pemgarda might not work against new strains, the FDA announced the medication is effective against KP.3.1.1, the dominant variant. In August, the FDA said early data ...

A replacement for a key COVID-19 antibody drug that has been used to protect immunocompromised Americans could be available within months, executives for drugmaker AstraZeneca said Thursday, after ...

(CNN) - A rare drug-resistant flu variant has been detected in at least two people in the United States. According to a new report from the Centers for Disease Control and Prevention, the variant has ...

Experts believe the dual mutant flu variant is low-risk because it only appears in 1% of samples collected between May 2023 and February 2024. (Copyright 2024 by CNN ...